Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.
about
Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseasesMorphoproteomic confirmation of an activated nuclear factor-кBp65 pathway in follicular thyroid carcinomaNanoparticle-mediated drug delivery for treating melanomaMRP3: a molecular target for human glioblastoma multiforme immunotherapy.Intra-arterial carboplatin as a salvage strategy in the treatment of recurrent glioblastoma multiforme.Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma.IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway.Progress on antiangiogenic therapy for patients with malignant glioma.Recombinant single-chain variable fragment antibodies against extracellular epitopes of human multidrug resistance protein MRP3 for targeting malignant gliomas.Translational possibility of [(18) F]Mefway to image serotonin 1A receptors in humans: Comparison with [(18) F]FCWAY in rodents.8-Methoxypsoralen is a competitive inhibitor of glutathione S-transferase P1-1Association between DNA methylation and multidrug resistance in human glioma SHG-44 cellsMolecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differencesCircumventing tumor resistance to chemotherapy by nanotechnologyA phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03.Expression and significance of glucose transporter-1, P-glycoprotein, multidrug resistance-associated protein and glutathione S-transferase-π in laryngeal carcinomaAcetate supplementation induces growth arrest of NG2/PDGFRα-positive oligodendroglioma-derived tumor-initiating cellsGrowth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π-activated nitric oxide donor PABA/NO in malignant gliomas.Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrestMembrane transporter proteins: a challenge for CNS drug development.Brain tumors and epilepsy.Drug delivery to brain tumors.One of the hottest topics in epileptology: ABC proteins. Their inhibition may be the future for patients with intractable seizures.Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain.Pharmacotherapy for adults with tumors of the central nervous system.Drug interactions at the blood-brain barrier: fact or fantasy?Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paperSeizures in low- and high-grade gliomas: current management and future outlook.Epilepsy in the cancer patient.Epilepsy in patients with a brain tumour: focal epilepsy requires focused treatment.Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments.Novel approaches to glioma drug design and drug screening.The molecular mechanism of resistance to methotrexate in mouse methotrexate-resistant cells by cancer drug resistance and metabolism SuperArray.Mechanisms and therapeutic potential of inhibiting drug efflux transporters.Glioblastoma entities express subtle differences in molecular composition and response to treatmentEmerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters.LRIG1 enhances chemosensitivity by modulating BCL-2 expression and receptor tyrosine kinase signaling in glioma cells.Role of Glutathione-S-transferases in neurological problems.Multidrug resistance-associated protein 1 decreases the concentrations of antiepileptic drugs in cortical extracellular fluid in amygdale kindling rats.Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II.
P2860
Q24601963-88F6E6DB-2F25-4A2C-9567-2FC9415046D5Q24630133-E9E39538-DB68-408B-9497-CD6C7E5511B5Q26798379-78A5DB07-8A73-4B3F-BD1C-62049045FA39Q30988770-4416CBC0-79A2-4842-AA56-8CCEB5BD28EDQ33416019-FC7DC9EF-64C3-43BE-9A95-7985AB3BF5C9Q33474188-0AB870C5-775B-4484-91C9-EDDF1BF31983Q33709922-3B7AF9AB-3FDB-45CC-9598-C265E5142C91Q33773189-EB6A6FC5-7728-4380-BF20-239B594FB1E9Q33886564-D52A718A-9A47-474A-93F2-EC881D3F07C4Q34041532-5A9094AC-A233-4EFA-BE02-CC57E8446514Q34265397-2BF7A509-BDB8-4CED-8D2D-E3EEC8883D40Q34540841-EBE6557C-A51C-42B0-94B4-A10207F1EFB4Q34608061-2DE488C0-F558-4C18-9A3D-6B1C08F19157Q34618357-EDD8685E-9D4F-4EBC-949B-CFE15860C20AQ34977381-4F869FF6-5ADD-41D4-84F3-ABDACF408A5AQ34993686-BA66FDB8-F484-4FA1-92DF-6FB18A64ED50Q35053662-BBC51580-8A38-4B02-A4C2-D53ABFB9712AQ35179525-BDEB308A-FD9F-438A-B90B-C0C1A02E0DEBQ35554585-893D8B2F-02E1-4487-B4B5-804E60DA9CA7Q36659167-F228D914-C926-49AA-8307-BA80DD9E0A87Q37174060-F1CDD02D-DB49-4E23-A8CB-DA1EE0DFB28DQ37186876-EF9CAE71-4276-4FF4-B27D-3AC6332DF4A8Q37204397-C01DE49D-661B-4B8A-BDF0-2946AC13476FQ37308322-76F48695-B7C2-4859-90DC-42D5C0947E41Q37353276-B3DA8CA2-4EED-4113-8534-C7BE3064FBEBQ37362486-F9FBCACD-9EBD-432B-8975-298A898448A8Q37608106-5E0AC13D-7D22-4363-AC04-C7870503FB4CQ37752365-ADCEFD11-0525-46B4-B3BD-5E0CA962AD0DQ37838314-1B822BD6-0D6C-43CE-97B3-8BF4824FACC0Q37968607-C7E3C9EC-1841-41EA-8EE6-9F9ABB48A969Q38055318-CE5E4C8B-66B2-48C1-92B2-1834AA6A8C40Q38112184-B39395A4-8C36-4BEB-BC24-7674DFC33E0FQ38310529-962B5508-C70D-4349-BD80-7BD3852A2985Q38388828-53C9B786-877B-42E3-9C7F-0EBB383599D8Q38697178-52370D0E-0527-49C7-B661-6EA1FE67F729Q38869922-3D70AF78-3BE2-44AF-BB6A-7C82688BE4B6Q38973067-841CFD9D-4E6D-4286-B9D0-18AB5279DADEQ38992254-A89C7286-10FD-4A55-A1C5-292CB88B725BQ39018998-AB067F7B-C116-436D-BA0F-49B5D4A227C3Q39245903-410F5F82-653B-477B-B712-B94F71AFC875
P2860
Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.
@en
Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.
@nl
type
label
Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.
@en
Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.
@nl
prefLabel
Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.
@en
Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.
@nl
P2093
P50
P1476
Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma
@en
P2093
A Salmaggi
F L Sciacca
L Vitellaro-Zuccarello
P2860
P2888
P304
P356
10.1007/S11060-004-6152-7
P577
2005-09-01T00:00:00Z